RecruitingNot ApplicableNCT05510817

Multiparametric Assessment to Investigate Prognostic Factors for Disease Evolution a nd Evolutionary Patterns of Cognitive Status in RRMS

Multiparametric Clinical, Radiological, Neuropsychological, and Neurophysiological Assessment to Investigate Prognostic Factors for Disease Evolution and Treatment Response in MS: a Prospective Study.


Sponsor

University Hospital of Mont-Godinne

Enrollment

50 participants

Start Date

Jun 6, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This prospective study combining non conventional MRI techniques, neuropsychological screening tools, and a neurophysiological work-up using a sensitive and validated battery, will evaluate the predictive value of these measures and will explore the changes of the cognitive scores from baseline.


Eligibility

Min Age: 18 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This study tracks cognitive changes (thinking, memory, and processing speed) in people who have had relapsing-remitting multiple sclerosis (MS) for less than 10 years, using brain MRI and other tests. The goal is to understand what factors predict whether someone's cognition will worsen over time. **You may be eligible if...** - You have been diagnosed with active, relapsing-remitting MS for less than 10 years - You are between 18 and 50 years old - You have not had a relapse or taken steroids in at least the past month - You are starting or switching a disease-modifying therapy for MS - You are able to give informed consent **You may NOT be eligible if...** - Your MS has been present for more than 10 years - You have had a relapse or taken steroids in the past month - You have conditions other than MS that could affect cognition (e.g., psychiatric illness, drug or alcohol use) - You are unable to have an MRI - You have progressive MS (not the relapsing-remitting type) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMultiparametric assessment

neuropsychological assessment, PRO measures, non-conventional MRI metrics


Locations(1)

CHU UCL Namur site Godinne

Yvoir, Namur, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05510817


Related Trials